Evidence map›Paper›PMID 36355178›Full record

ArticleMetabolites2022

Pancreatic Cancer Cell-Conditioned, Human-Derived Primary Myotubes Display Increased Leucine Turnover, Increased Lipid Accumulation, and Reduced Glucose Uptake.

Solveig A Krapf, Jenny Lund, Awais Ur Rehman Saqib, Hege G Bakke, Arild C Rustan, G Hege Thoresen, Eili T Kase

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Solveig A KrapfSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, NO-0316 Oslo, Norway.
Jenny LundSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, NO-0316 Oslo, Norway.ORCID 0000-0002-0744-8268
Awais Ur Rehman SaqibSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, NO-0316 Oslo, Norway.
Hege G BakkeSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, NO-0316 Oslo, Norway.
Arild C RustanSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, NO-0316 Oslo, Norway.
G Hege ThoresenSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, NO-0316 Oslo, Norway.
Eili T KaseSection for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, NO-0316 Oslo, Norway.
University of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic alterations occurring in cancer cells have been seen to also occur in other tissues than cancerous tissue. For instance, cachexia, peripheral insulin resistance, or both are commonly seen in patients with cancer. We explored differences in substrate use in myotubes conditioned with the medium from a pancreatic cancer cell line, PANC-1, or primary human pancreatic cells, hPECs. Protein turnover was assessed using scintillation proximity assay, glucose and oleic acid handling were analyzed by substrate oxidation assay. We performed qPCR to study gene expression and immunoblotting and proteomic analyses to study protein expression. PANC-1-conditioned myotubes had an imbalance in protein turnover with decreased accumulation, increased decay, and decreased

Indexed as

cachexiacross talkenergy metabolismprotein metabolism

Identifiers

PMID36355178
PMCPMC9696174
OpenAlexW4308772748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.